Beo Therapeutics ApS

CVR 39880377 · Private limited company (ApS) · Active · Low risk

Beo Therapeutics ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 7 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 40k and a net result of DKK 4,985.

Bankruptcy risk for Beo Therapeutics ApS

0.5%
probability of bankruptcy within 12 months
Low risk

0.4 × the average (1.41%) · higher risk than 60% of active Danish companies

Lowest riskHighest risk

Increases the risk

Reporting classReporting class B, mikrovirksomhed · bankruptcy rate 23.5%2.7×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×
Equity vs. share capital1× · bankruptcy rate 12.9%1.5×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Number of CEOs0 · bankruptcy rate 12.7%1.4×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
CEOs in total (historical)0 · bankruptcy rate 12.4%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×

Reduces the risk

Negative equityNo · bankruptcy rate 5.1%0.58×
Loss for the yearNo · bankruptcy rate 5.3%0.60×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Return on assets0%–5% · bankruptcy rate 5.8%0.66×
Published annual reports5–10 · bankruptcy rate 6.3%0.72×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×
Capital changes1 · bankruptcy rate 7.0%0.80×
Age (years)5–10 yrs · bankruptcy rate 7.0%0.80×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
39880377
Status
Active
Company type
Private limited company (ApS)
Founded
(8 years)
Address
Ole Maaløes Vej 3
2200 København N
Municipality
København
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 40k
Auditor
DVU STATSAUTORISERET REVISIONSANPARTSSELSKAB
Audit opted out
Yes

Warning signs

Annual reports filed late2 of 7
Missing annual reportNo
Negative equityNo
Equity ratio1.4%
Current ratio100%
Moves (last 2 years)1
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address167
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 0DKK -5,000
Net profitDKK 4,985DKK -4,910
EquityDKK 40kDKK 35k
Total assetsDKK 2.8mDKK 3.6m
CashDKK 2.7m–
Short-term debtDKK 2.7m–

Latest annual report: Reporting class B, mikrovirksomhed · auditor's statement: Andre erklæringer uden sikkerhed · DVU STATSAUTORISERET REVISIONSANPARTSSELSKAB.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 202513
1 Jan 2024 – 31 Dec 2024119
1 Jan 2023 – 31 Dec 2023145
1 Jan 2022 – 31 Dec 202223
1 Jan 2021 – 31 Dec 2021192 Late
1 Jan 2020 – 31 Dec 2020189 Late
26 Sep 2018 – 31 Dec 201965

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
Owner (100%)Rikke Christina NielsenCurrent
FounderRikke Christina NielsenCurrent

Address history (1 moves)

Ole Maaløes Vej 3, 2200 København N
c/o RC Nielsen, Nørremøllevej 240, 9800 Hjørring

Former names

Beo Therapeutics ApS – now
Beo Therapeutics IVS –

Other companies at the same address

Similar companies in København

Questions and answers about Beo Therapeutics ApS

Has Beo Therapeutics ApS gone bankrupt?

No, Beo Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Beo Therapeutics ApS?

Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.

Who is the auditor of Beo Therapeutics ApS?

Beo Therapeutics ApS most recently used DVU STATSAUTORISERET REVISIONSANPARTSSELSKAB.

When was Beo Therapeutics ApS founded?

Beo Therapeutics ApS was founded on 17 September 2018.

What is the equity of Beo Therapeutics ApS?

Equity was DKK 40k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.